Results 121 to 130 of about 55,552 (271)

Development and biological evaluation of Iinkjet printed drug coatings on intravascular stent [PDF]

open access: yes, 2016
Inkjet–printing technology was used to apply biodegradable and biocompatible polymeric coatings of poly(D, L lactide) with the antiproliferative drugs simvastatin (SMV) and paclitaxel (PCX) on coronary metal stents.
Blanchemain, Nicolas   +9 more
core   +1 more source

Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh   +5 more
wiley   +1 more source

Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers [PDF]

open access: bronze, 2018
Hiroto Yabushita   +19 more
openalex   +1 more source

Recurrent Spontaneous Coronary Dissection in Puerperium Precipitating in Cardiogenic Shock Prompted Coronary Artery Bypass Grafting

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Graphical summary of postpartum SCAD: (A) ECG with ST‐elevation; (B) surgical revascularization with BIMA and saphenous vein grafts; (C–D) coronary angiography showing RCA and LAD dissection; (E–F) intraoperative subepicardial hematoma of LM and LCx. ABSTRACT This case report details a rare instance of recurrent spontaneous coronary artery dissection ...
Lorenzo Giovannico   +7 more
wiley   +1 more source

Interfacing exogenous stents with human coronary artery by self-assembled coating: designs, functionalities and applications

open access: yesNPG Asia Materials
Drug-eluting stents are a commonly used treatment for coronary artery disease. However, the coatings used in drug-eluting stents have some limitations such as poor biocompatibility and drug loading capacity.
Feng Zhao   +14 more
doaj   +1 more source

Percutaneous Coronary Interventions in Stable and Acute Coronary Syndromes: Stent technology, lesion complexity and clinical outcome [PDF]

open access: yes, 2015
__Abstract__ Percutaneous coronary intervention (PCI) has brought a major revolution in the way we manage coronary artery disease. Since the first intervention by Andreas Grüntzig in 1977, development of the technology has been relentless and today ...
Magro, M. (Michael)
core  

Rationale and Design of the PASSIVATE‐CAP Trial: The Preventive Intervention Value of Drug‐Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques

open access: yesClinical Cardiology, Volume 49, Issue 1, January 2026.
PASSIVATE‐CAP Research Overview and Flowchart. ABSTRACT Background Patients with acute coronary syndrome (ACS) face a significantly increased risk of cardiovascular events due to vulnerable plaques. However, no clear evidence supports performing preventive percutaneous coronary intervention (PCI) for non‐flow‐limiting vulnerable plaques.
Zhongxiu Chen   +11 more
wiley   +1 more source

The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention

open access: yesClinical Cardiology, Volume 49, Issue 1, January 2026.
The effect of age on improvement in health‐related quality of life (HRQoL) after percutaneous coronary intervention (PCI)—Do older adults benefit from PCI equally to their younger peers in respect of HRQoL and symptom relief? ABSTRACT Introduction Percutaneous coronary intervention (PCI) is the first‐line therapy in patients scheduled for coronary ...
Laura Lappalainen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy